12.81

4.06% 0.50

After Hours: 12.75 -0.06 -0.47%

10 X Genomics Inc (TXG)

Overview News Price History Option Chain Financials Discussions Forecast

10 X Genomics Inc stock is traded at $12.81, with a volume of 3.95M. It is up +4.06% in the last 24 hours and up +0.08% over the past month. 10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

Previous Close:

$12.31

Open:

$12.5

24h Volume:

3.95M

Relative Volume:

1.05

Market Cap:

$1.42B

Revenue:

$631.73M

Net Income/Loss:

$-239.78M

P/E Ratio:

-6.3416

EPS:

-2.02

Net Cash Flow:

$-33.45M

1W Performance:

-3.76%

1M Performance:

+0.08%

6M Performance:

+6.75%

1Y Performance:

-34.81%

1-Day Range:

$12.27

$13.09

1-Week Range:

$11.88

$14.49

52-Week Range:

$6.78

$24.76

10 X Genomics Inc Stock (TXG) Company Profile

Name

10 X Genomics Inc

Sector

Healthcare (1159)

Industry

Health Information Services (55)

Phone

(925) 401-7300

Address

6230 STONERIDGE MALL ROAD, PLEASANTON, CA

Employee

1,306

Twitter

@10xgenomics

Next Earnings Date

2024-10-31

Latest SEC Filings

TXG's Discussions on Twitter

Compare TXG with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TXG 10 X Genomics Inc	12.81	1.51B	631.73M	-239.78M	-33.45M	-2.02
VEEV Veeva Systems Inc	275.43	46.10B	2.86B	780.66M	1.20B	4.72
TEM Tempus Ai Inc	66.34	10.54B	803.32M	-709.10M	-212.68M	-7.8003
DOCS Doximity Inc	61.82	12.48B	550.17M	201.35M	232.07M	1.00
HQY Healthequity Inc	92.98	8.05B	1.15B	96.70M	-161.99M	1.09
WAY Waystar Holding Corp	34.58	6.03B	906.14M	-52.62M	89.62M	-0.3621

10 X Genomics Inc Stock (TXG) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-13-25	Downgrade	Leerink Partners	Outperform → Market Perform
Sep-03-24	Initiated	Leerink Partners	Outperform
Jul-22-24	Upgrade	Jefferies	Hold → Buy
Jul-18-24	Downgrade	JP Morgan	Overweight → Neutral
Jul-10-24	Downgrade	Deutsche Bank	Buy → Hold
Jun-27-24	Downgrade	Wolfe Research	Outperform → Peer Perform
Jun-25-24	Downgrade	Guggenheim	Buy → Neutral
Jun-03-24	Resumed	Jefferies	Hold
May-01-24	Downgrade	TD Cowen	Buy → Hold
Dec-14-23	Initiated	Guggenheim	Buy
Dec-13-23	Initiated	Wolfe Research	Outperform
Dec-12-23	Upgrade	BofA Securities	Underperform → Neutral
Jul-05-23	Resumed	JP Morgan	Overweight
May-10-23	Initiated	Barclays	Overweight
Mar-31-23	Initiated	Stephens	Overweight
Feb-02-23	Initiated	UBS	Neutral
Dec-14-22	Initiated	Deutsche Bank	Buy
Aug-18-22	Downgrade	Goldman	Neutral → Sell
Jul-25-22	Initiated	Canaccord Genuity	Buy
Jul-15-22	Downgrade	BofA Securities	Neutral → Underperform
Jul-15-22	Downgrade	William Blair	Outperform → Mkt Perform
Oct-15-21	Resumed	Cowen	Outperform
Sep-14-21	Downgrade	BofA Securities	Buy → Neutral
Mar-15-21	Initiated	William Blair	Outperform
Dec-02-20	Initiated	Goldman	Neutral
Sep-09-20	Initiated	Morgan Stanley	Overweight
Jul-10-20	Initiated	Stifel	Buy
Mar-05-20	Initiated	Guggenheim	Buy
Jan-07-20	Initiated	Citigroup	Buy
Oct-07-19	Initiated	BofA/Merrill	Buy
Oct-07-19	Initiated	Cowen	Outperform
Oct-07-19	Initiated	JP Morgan	Overweight
Sep-24-19	Initiated	Evercore ISI	Outperform

View All

10 X Genomics Inc Stock (TXG) Latest News

02:20 AM

Tandem Diabetes, iRhythm, agilon health, Fortrea, and 10x Genomics Shares Skyrocket and Plummet, What You Need To Know - Yahoo Finance

02:20 AM

Tandem Diabetes, iRhythm, agilon health, Fortrea, and 10x Genomics Shares Skyrocket and Plummet, What You Need To Know | FinancialContent - FinancialContent

02:20 AM

01:43 AM

Does 10x Genomics Inc. offer margin of safetyFree Weekly Earnings Watchlist - thegnnews.com

01:43 AM

10:03 AM

Zacks.com featured highlights include Tsakos Energy Navigation Limited, 10x Genomics, Pan American Silver, Wolverine World Wide and Interface - TradingView

10:03 AM

Aug 11, 2025

Will Breakout in 10x Genomics Inc. Sustain Through Next WeekIntraday Trend Analysis for Fast Gains Released - beatles.ru

Aug 11, 2025

Price Floor Holding on 10x Genomics Inc. — Rebound PossibleShort Term Buy Zone Stock Alerts Signal Entry - metal.it

Aug 11, 2025

Aug 10, 2025

10x Genomics to Acquire Scale Biosciences - FinSMEs

Aug 10, 2025

Aug 08, 2025

Why 10x Genomics (TXG) Is Down 6.0% After Tariff-Driven Q2 Revenue Surge and Guidance Update - simplywall.st

Aug 08, 2025

10x Genomics: UBS maintains a 'Neutral' Rating, The Target Price is $13 - AInvest

Aug 08, 2025

10x Genomics (NASDAQ:TXG Shareholders Incur Further Losses as Stock Declines 4.8% This Week, Taking Five-year Losses to 88% - 富途牛牛

Aug 08, 2025